Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
The (Raleigh) News & Observer on MSN2h
Live updates: See results for NC lieutenant governor and other Council of State racesBoth candidates support reinstating coverage under the State Health Plan of weight-loss drugs such as Wegovy, Saxenda and ...
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...
Hosted on MSN5h
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey saysYet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—most Americans wouldn’t take them, ...
Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback